Clinical Trial Update: The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tolerability and effects of AZD8848 in subjects with allergic asthma; the study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• AZD8848

Snippet

Sponsor: AstraZeneca | Conditions: Allergic Asthma | Phase 2 | Status: COMPLETED | Results posted: 2016-01-26